By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cerus Corporation 

2411 Stanwell Drive

Concord  California  94520   U.S.A.
Phone: 925-288-6000 Fax: 925-288-6001


Medical Device



Company News
Cerus (CERS) To Release Third Quarter 2016 Results On November 3, 2016 10/20/2016 11:07:22 AM
Cerus (CERS) Announces That Hemolife Fundación Banco Nacional De Sangre Has Entered Into Routine Use Of The INTERCEPT Blood System 10/10/2016 9:06:38 AM
Cerus (CERS) Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4) 10/5/2016 8:36:30 AM
Cerus (CERS) Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 9/7/2016 11:28:44 AM
Cerus (CERS) To Present At The Baird 2016 Healthcare Conference On September 8, 2016 9/1/2016 10:49:26 AM
Cerus (CERS) Release: FDA's New Recommendation For Universal Zika Risk Reduction Of Blood Components Includes Use Of Pathogen Reduction 8/29/2016 8:41:14 AM
Vivek Jayaraman Appointed As Cerus (CERS)’s Chief Commercial Officer 8/9/2016 11:14:26 AM
Cerus (CERS) Reports Second Quarter 2016 Results 8/5/2016 10:33:08 AM
Cerus (CERS) To Release Second Quarter 2016 Results On August 4, 2016 7/21/2016 10:22:28 AM
Cerus (CERS) Provides An Update On Adoption By Blood Centers Of America Members For The INTERCEPT Blood System For Platelets And Plasma 7/11/2016 10:20:02 AM